Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: S&P Capital IQ Quantitative Report
$92.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Abbott Laboratories Reaffirms FY 2013 EPS Guidance


Wednesday, 17 Jul 2013 07:44am EDT 

Abbott Laboratories confirmed its fiscal 2013 ongoing earnings per share (EPS) guidance and expects EPS to be in the range of $1.98 to $2.04. Including these net specified items, projected EPS from continuing operations under Generally Accepted Accounting Principles (GAAP) would be $1.39 to $1.45 for fiscal 2013. According to I/B/E/S Estimates, analysts were expecting the Company to report EPS of $2.01 for fiscal 2013.